Recursion Pharmaceuticals, Inc.: meeting of 12 Nov 2024

Votes reported on Form N-PX, item by item

98 Form N-PX filers reported votes at the Recursion Pharmaceuticals, Inc. meeting of 12 Nov 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

2 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management248,004 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

171 vote records from 92 filers. 0 of the 91 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.9% for0.0% against1.1% other0.0% against management92 filers100.0% for0.0% against0.0% against management15,570,758 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

177 vote records from 97 filers. 12 of the 96 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

86.6% for11.3% against2.1% other12.5% against management97 filers95.6% for4.3% against0.1% other4.4% against management46,079,728 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Recursion Pharmaceuticals, Inc. meeting?

98 Form N-PX filers reported votes at the meeting of 12 Nov 2024. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Recursion Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Recursion Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Recursion Pharmaceuticals, Inc. with a meeting date within three days of 12 Nov 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.